Thomas Braxton King
Chief Executive Officer, Alexza Pharmaceuticals Inc.
Companies
- ACHIEVE LIFE SCIENCES, INC.Board member Mar 30, 2023 to now1
- ACHIEVE LIFE SCIENCES, INC.Chair Jan 14, 2025 to Jan 14, 20252
- TFF Pharmaceuticals, Inc.Board member Dec 15, 2023 to Jul 8, 20243
- Satsuma Pharmaceuticals, Inc.Board member Sep 12, 2019 to Jun 8, 20234
- VivusBoard member May 24, 2017 to Feb 24, 20205
- VivusChief executive officer Jan 30, 2018 to Jan 30, 20186
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ACHIEVE LIFE SCIENCES, INC. ACHV315,142 shares7$2.0M at $6.38Sep 4, 2025
- TFF Pharmaceuticals, Inc.1,583 shares8Jul 3, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 4, 2025Sold 139,858 shares at $2.77 of ACHIEVE LIFE SCIENCES, INC.7
- Sep 4, 2025Exercised options 455,000 shares of ACHIEVE LIFE SCIENCES, INC.7
- Jul 3, 2024Granted 1,583 shares of TFF Pharmaceuticals, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARACHIEVE LIFE SCIENCES, INC., Chair
- 3
- 4
- 5SEC EDGARVivus, Board member
- 6SEC EDGARVivus, Chief executive officer
- 7
- 8